Rivaroxaban enhances thrombin-induced endothelial progenitor cell activation
Atherosclerosis(2020)
Abstract
Background and Aims: Factor Xa (FXa) and thrombin exert non-haemostatic cellular effects. Late-outgrowth endothelial cells (OECs) are a type of endothelial progenitor cells. We investigated the effect of rivaroxaban, a direct oral anticoagulant which specifically inhibits FXa’s activity, on FXa-and thrombin-induced OEC activation, using as activation markers the ICAM-1 membrane expression and MCP-1 secretion.
MoreTranslated text
Key words
thrombin-induced
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined